Could CAR-T cells carrying collagen targeted IL-12 be a safe therapy for #ProstateCancer? A team including Prostate Cancer UK fellow @Ko1ssk.bsky.social & Jun Ishihara @imperialcollegeldn.bsky.social share new results in @natbiomedeng.nature.com. Grab a ☕ and read: doi.org/10.1038/s415...

📢Careers in Research Webinar📢 🤔Got a great idea, but not sure how to turn it into a clinical trial? 📉Curious about careers in trials – stats, methods, data? Register to explore how partnering with a CTSU can support researchers at every stage 👇 events.teams.microsoft.com/event/2b9a0b...

Calling all Clinician and AHPs 👨‍⚕️ 👩‍⚕️ Apply for our free 18-month flagship Clinical Champions Programme. Become a leader in transforming care and support for men impacted by prostate cancer. Apply today 👉 bit.ly/46I5Fn9

Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.

Could genetic information help personalise radiotherapy to reduce rectal toxicity? A team led by Dr Alan McWilliam and Artemis Bouzaki at @manchester.ac.uk report exciting new findings in Clinical Cancer Research. Grab a ☕ and read: doi.org/10.1158/1078...

🧵[1/6] 📣 Big news for clinical prostate cancer researchers! The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research. Learn more 👇 prostatecanceruk.org/research/for...

🎵 Movin’ for Men’s Health! One of our brilliant researchers, Prof. Charlotte Bevan, is hosting a Soul Nite to raise funds for @prostateuk.bsky.social and Movember. 📅 When: 8pm, 8th November 📍 Where: The Camden Club, London Find out more and register ⤵️ buff.ly/vidaQg8

Last month, we launched our new One-to-One support service for Black men, which operates alongside our existing peer support service. Please signpost Black men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer. 💙

🗣️ Just 1 week left to share your views on the 10-year NHS England workforce plan! Share your views on: 🔜Future NHS workforce models 📋How to support delivery of the 3-shifts 🥼How to align staff with the future of the NHS in England 📅Due 7 Nov buff.ly/DuyIVqU

Could radiomic features guide adaptive radiotherapy to minimise rectal toxicity? A brilliant team led by Prof. Bill Nailon, Prof. Duncan McLaren and Dr Zhuolin Yang at @uni-of-edinburgh.bsky.social share interesting new findings in phiRO. Grab a ☕ and read: doi.org/10.1016/j.ph...

📣Each From Ideas to Innovation session will feature a reflection by a Patient Research Partner (PRP) -a man or family member affected by #ProstateCancer. 🙏We’re grateful to our PRPs for sharing their stories & shaping our research. ⬇️ Register to attend. prostatecanceruk.org/research/for...

🗣️ Hear from experts sharing the latest data on the use of genetic information in prostate cancer care at the high-profile conference, Genomics and Prostate Cancer. 📅 Friday 12 December 📍 The Royal Society of Medicine, London ➡️ Secure your place: bit.ly/4pS5cGz

There’s still time to share your thoughts on the 10-year NHS England workforce plan! Share your views on: 🔜Future NHS workforce models 📋How to support delivery of the 3-shifts 🥼How to align staff with the future of the NHS in England 📅Due 7 Nov buff.ly/DuyIVqU

The October edition of Research News is here! Read more about: 🚴 Tour de 4. 🤝 Upcoming meetings and webinars. 🌱 A personal development resource. 🗣️ Speakers at our researcher event, From Ideas to Innovation. 💰 Funding opportunities. 📖 Read it here: prostatecanceruk.org/research/for...

[1/9] 🔎 Let’s take a closer look at the exciting findings from the Prostate Cancer UK-funded study led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk recently published in @jama.com 🧵.

Can expanding germline testing improve #ProstateCancer risk detection in men of African ancestry? A great team effort led by Prof Vanessa Hayes with Prof Ros Eeles from @icr.ac.uk, and the PPCG, published in @natcomms.nature.com Grab a ☕ and read: doi.org/10.1038/s414...

📢 @cancerresearchuk.org has refreshed their career support for clinical academics, aiming to address some of the specific challenges they face. 💻 Join their webinar on 19 November to learn more and ask your questions. Register using the link below! ⤵️ buff.ly/CZx2ANJ

Congratulations team!! Great to see data from STOPCAP presented on such an international platform!

Members of our Research Team are at #ESMO25 in Berlin this weekend, if you spot them be sure to say hello, or guten tag 😃

Our fantastic @prostateukprofs.bsky.social career development fellow @juanjimenezvacas.bsky.social takes a closer look at a potential new treatment approach for #ProstateCancer that has stopped responding to existing therapies ⬇️.

A one year opportunity has arisen for a lab-based molecular scientist to join the Cancer Genetics team on the Prostate Cancer UK funded project “Identifying patients with aggressive prostate cancer by detecting molecular subtypes in urine”. Starting Feb 2026. Please contact me. bit.ly/4o9a6xD

The Government wants to hear from you to shape a 10-year NHS England workforce plan! Share your views on: 🔜Future NHS workforce models 📋How to support delivery of the 3-shifts 🥼How to align staff with the future of the NHS in England 📅Due 7 Nov buff.ly/DuyIVqU

An exciting opportunity has arisen for a senior bioinformatician to join the Cancer Genetics team on the Prostate Cancer UK funded project “Identifying patients with aggressive prostate cancer by detecting molecular subtypes in urine”. 3 years starting in Feb 2026. 🧬🖥️ bit.ly/3Wt3Lk8

Could targeting MCL1 be a new treatment approach for hormone therapy-resistant #ProstateCancer? A study in @natcomms.nature.com by @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social and the @icr.ac.uk team explores precision therapy strategies. Grab a ☕ and read: doi.org/10.1038/s414...

Exciting opportunity in this fantastic team ⬇️

Missed our RCGP session on the latest in prostate cancer care for GPs? Catch up anytime. Watch on-demand now ➡️ bit.ly/46nHUAv #ProstateCancer I #GPEducation

Could IGF-1R recruitment to chromatin regulatory regions be important in #ProstateCancer? A brilliant team based @ndsurgicalsci.bsky.social share exciting new findings in Cancer Medicine. Grab a ☕ and read: doi.org/10.1002/cam4...

🎦 Watch Dr Bunmi Olajide in collaboration with @nasgp.bsky.social for practical guidance on prostate cancer detection, PSA testing & tackling health inequalities. ➡️ View here bit.ly/46a5WyZ

💙 1 in 8 UK men will develop prostate cancer — but the risk is twice as high for men of African ancestry. Yet, research in this group is still limited. That needs to change. #MensHealth #ProstateCancer

Could imaging, genetic and biomarker tests improve early #ProstateCancer detection? A team led by Prof Prabhakar Rajan @qmbci.bsky.social explore different detection strategies in their latest publication in @bjuijournal.bsky.social. Grab a ☕ and read: doi.org/10.1002/bco2...

🎦 On-demand webinar: Dr Bunmi Olajide with @NASGP on early detection of prostate cancer — risk assessment, PSA testing & health inequalities. ➡️Watch here: bit.ly/46a5WyZ

Don't miss this: Claire Fletcher, part of the Hormone Dependent Cancer founding group, shares why this upcoming event is a must-attend for anyone working in the field. PLUS: abstract deadline extension to 1/10 bit.ly/4fqWdqL

Can specific gene mutations drive CDK7 inhibitor resistance in #ProstateCancer? A brilliant team led by @simak.bsky.social @imperialcollegeldn.bsky.social share exciting new findings in @embojournal.org. Grab a ☕ and read: doi.org/10.1038/s443...

🤝Our mentoring scheme brings #ProstateCancer researchers from different institutions together. 🚀To help navigate challenges & build successful careers - delivering maximum impact for men. 💪Together, we're building a stronger, more connected, research community. prostatecanceruk.org/research/for...

🤝Our mentoring scheme brings #ProstateCancer researchers from different institutions together. 🚀To help navigate challenges & build successful careers - delivering maximum impact for men. 💪Together, we're building a stronger, more connected, research community. prostatecanceruk.org/research/for...

Exciting🌟From Ideas to Innovation🌟Updates! 👩‍🔬Sessions chaired by Prostate Cancer UK Career Acceleration Fellows. 🎤30 brilliant researchers sharing Research Snapshots. 🚀All #ProstateCancer researchers welcome. 🗓️Check the webpage for agenda & registration. 👇 prostatecanceruk.org/research/for...

🎦 Watch on-demand: Dr Bunmi Olajide & @NASGP.bsky.social present a focused session on early detection of prostate cancer in the UK. Tailored for primary care, the webinar covers: 🔷Risk assessment 🔷PSA testing 🔷Tackling health inequalities ➡️View here bit.ly/46a5WyZ

The September edition of Research News is here! Find out more about: 💊 Exciting Research Findings. 🤝 Researcher Mentoring Scheme. 🏆 A Researcher Achievement. 💻 Upcoming New Seminar Series. 💰 Funding Opportunities. 📖 Read it here: prostatecanceruk.org/research/for...

👇A great opportunity to work on exciting new #ProstateCancer research in the brilliant @bevanlab.bsky.social

🔊 Don’t miss Dr Bunmi Olajide on @nasgp.bsky.social! Key prostate cancer updates for primary care in one podcast. ➡️ Listen now bit.ly/3VGEBOC

Could faster MRI scans allow more men to receive timely #ProstateCancer diagnoses? Research published in @jama.com led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk compares the efficacy of shortened versus standard-length scans. Grab a ☕ & read: doi.org/10.1001/jama...

🎧 Tune in to our new @nasgp.bsky.social podcast with Dr Bunmi! Everything primary care needs to know on prostate cancer: 🔵 Epidemiology & risk factors 🔵 Health inequalities 🔵 NICE NG12 & PSA thresholds 🔵 mpMRI, DRE & the TRANSFORM trial ➡️ Listen on Spotify: bit.ly/4maj9ME

How confident are you in spotting & managing prostate cancer early? In our latest podcast with @nasgp.bsky.social & Dr Bunmi, we cover: 🔷UK epidemiology & risk factors 🔷PSA thresholds, mpMRI & DRE 🔷Health inequalities & TRANSFORM ➡️ A must-hear for primary care: bit.ly/3VGEBOC

Can microbial communities be linked to specific cancer types, including #ProstateCancer? A team @UeaMedical.bsky.social including Career Acceleration Fellow @AbrahamGihawi.bsky.social use @GenomicsEngland.bsky.social data to examine these links. Grab a ☕ and read: buff.ly/HRJA9oc

[1/8] 🔎 Let’s take a closer look at the exciting findings from the Prostate Cancer UK funded study led by Prof Gerhardt Attard and team @ucl.ac.uk recently published in @cp-cell.bsky.social 🧵.

Could transcriptome signatures identify men with advanced #ProstateCancer most likely to benefit from chemotherapy? A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social. Grab a ☕ and read: doi.org/10.1016/j.ce...

Dr Abel Tesfai shares key insights from experts from our first ever Health Inequalities Conference and outlines steps being taken to strengthen the real-world evidence landscape for Black men. Read more about it here ⤵️ bit.ly/3ZNWw8K #HealthEquity #ProstateCancer

Could #AI support clinicians to accurately contour organs-at-risk before #ProstateCancer radiotherapy? A team of researchers @qubelfastofficial.bsky.social led by Dr Conor McGarry compare AI- and clinician-generated rectum contours. Grab a ☕ and read: doi.org/10.1088/2057...

Health engagement map! Thanks to your commitment to health education & training, support is reaching men across the UK.💙 🗺️ Explore our map to see what we’ve achieved and how together we’re striving for a world where no man dies from prostate cancer ⬇️

Improve the Consultation Toolkit! The Toolkit supports you in discussing prostate health with patients. It’s been live for a while, and we’d love to know what you think! Share your thoughts to help us refine it! Fill out the the short survey here! ➡️